Deductible Buy-Downs: How Plan Sponsors Lower Out-of-Pocket Costs Without Raising Premiums
By the PlanVantage engine teamPublished July 24, 20253 min read
A deductible buy-down is one of the most common, and most misunderstood, plan design moves in employee benefits. When done well, it improves the member experience without materially raising employer cost. When done poorly, it quietly inflates premiums for years. This guide unpacks how buy-downs work, when they make sense, and how to price them correctly.
What is a Deductible Buy-Down?
A deductible buy-down is a plan design change that lowers the deductible (and sometimes the out-of-pocket maximum) on a health plan in exchange for a higher premium. The "buy-down" refers to the employer or member "buying down" the deductible from a higher amount to a lower one.
Example: A plan with a $3,000 deductible could be bought down to $1,500. The plan's actuarial value goes up, members pay less when they use care, and premiums rise to fund the richer benefit.
How Buy-Downs Are Priced
The cost of a buy-down depends on three actuarial factors:
1. Induced Utilization
Lower cost sharing raises utilization, but modestly. The induced-demand factors in the federal AV Calculator span about 1.00 at the bronze level to about 1.15 at platinum, so on the order of half a percentage point of extra utilization per point of actuarial value. Price the induction: do not assume it is zero, and do not assume it is large.
2. Leverage
Because deductibles are fixed dollar amounts, medical inflation makes the same deductible "cheaper" each year: buy-down costs grow faster than overall trend.
3. Population Health
A high-claimant population gets more benefit from lower deductibles than a healthy one, which changes the value calculation.
Rule of thumb: a $500 deductible buy-down on a PPO with average utilization typically costs 2–4% of premium. The exact number depends heavily on the underlying claims distribution.
When Does a Buy-Down Make Sense?
Good Candidates
- • Employers with high member dissatisfaction about cost-sharing
- • Workforces with significant chronic-condition prevalence
- • Recruitment-sensitive sectors competing on benefits
- • Plans paired with a buy-up HDHP for choice
Poor Candidates
- • Employers already at the top of the market on premium
- • Populations that are mostly low-utilizers
- • Plans where the OOP max, not the deductible, is the binding constraint
- • Sponsors who can't sustain the recurring premium increase
Buy-Down vs. Contribution Strategy
Many sponsors confuse a buy-down with a contribution change. They aren't the same thing.
- Buy-down: changes the plan's benefit design (deductible, OOP max). Affects total plan cost. Visible to every member when they use care.
- Contribution change: changes how total plan cost is split between employer and employee payroll deduction. Doesn't affect the plan itself.
A sponsor can lower employee premiums without touching the deductible by increasing the employer contribution. The two levers solve different problems and should be modeled together, not interchangeably.
Key Takeaways
Deductible buy-downs are a powerful lever, but the cost compounds with medical trend, and the benefit isn't evenly distributed across the workforce. Price them as a multi-year commitment, not a one-year win.
Consultant's checklist: Before recommending a buy-down, model (1) the three-year cost trajectory under your trend assumption, (2) the distribution of impact across high- and low-utilizers, and (3) the contribution strategy required to keep the change member-positive.